2026 NPPES data Pharmacotherapy Pharmacist NPI 1750538872 PHARM.D.
Verify on CMS →

JEFFREY GILDOW, PHARM.D.

Pharmacotherapy Pharmacist in MACY, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
397
Medicare Part D claims · 83 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
70%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: JEFFREY GILDOW, PHARM.D. is a Pharmacotherapy Pharmacist ([object Object]) practicing in MACY, Nebraska with a Medicare Part D prescribing footprint of 397 claims across 83 beneficiaries — 30% brand-name prescribing .

What stands out: JEFFREY GILDOW, PHARM.D. filed 397 Medicare Part D claims in 2023 across MACY, Nebraska. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JEFFREY GILDOW, PHARM.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 08/20/2008

NPI 1750538872

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

397 0% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Nebraska

How Pharmacotherapy Pharmacist compares to other specialties among Nebraska providers

Nebraska providers

Pharmacotherapy Pharmacist share within Nebraska

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within Nebraska

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JEFFREY GILDOW, PHARM.D. is a Pharmacotherapy Pharmacist provider practicing in MACY, Nebraska, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D.. NPI: 1750538872. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JEFFREY GILDOW, PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D. credentials at 923 SENIOR CIR, MACY, NE, 68039, with a listed phone of (402) 837-5381. NPI 1750538872 was issued on 08/20/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GILDOW most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 397 prescription claims written by this provider, covering 83 Medicare beneficiaries and totaling roughly $40K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

923 SENIOR CIR
MACY, NE 68039

Provider Details

NPI 1750538872
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D.
Gender Male
NPI Issued 08/20/2008

Brand vs generic prescribing mix · Above average

JEFFREY GILDOW, PHARM.D. — brand share 30.0%
Specialty average (est.)

30% brand-name claims vs 70% generic, on 397 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

397
Total Claims
$40K
Total Drug Cost
83
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
397
Total Day Supply
11,212
Brand vs Generic
30% brand / 70% generic
Brand Drug Cost
$37K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
65.9 years
Avg HCC Risk Score
3.45
Gender Split
65% female / 35% male
Age Distribution
<65: 33, 65-74: 37, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pantoprazole Sodium
27
Synthroid
Levothyroxine Sodium
24
Omeprazole
22
Lisinopril
19
Amlodipine Besylate
18
Albuterol Sulfate Hfa
Albuterol Sulfate
17
Eliquis
Apixaban
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How JEFFREY GILDOW, PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

JEFFREY GILDOW, PHARM.D.'s 397 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as GILDOW.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JEFFREY GILDOW, PHARM.D.'s specialty?
JEFFREY GILDOW, PHARM.D. specializes in Pharmacotherapy Pharmacist and practices in MACY, Nebraska. Credentials: PHARM.D..
How much does JEFFREY GILDOW, PHARM.D. prescribe under Medicare Part D?
In 2023, JEFFREY GILDOW, PHARM.D. wrote 397 Medicare Part D claims totaling $40K in drug costs for 83 beneficiaries.
Where is JEFFREY GILDOW, PHARM.D. located?
JEFFREY GILDOW, PHARM.D. is located at 923 SENIOR CIR, MACY, NE, 68039. Phone: (402) 837-5381.
What is JEFFREY GILDOW, PHARM.D.'s NPI number?
JEFFREY GILDOW, PHARM.D.'s National Provider Identifier (NPI) is 1750538872, issued on 08/20/2008.
Does JEFFREY GILDOW, PHARM.D. prescribe more brand-name or generic drugs?
JEFFREY GILDOW, PHARM.D.'s prescribing is 30% brand-name and 70% generic drugs by claim count, with $37K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does JEFFREY GILDOW, PHARM.D. prescribe most often?
Based on 2023 Medicare Part D data, JEFFREY GILDOW, PHARM.D.'s most frequently prescribed drugs include Pantoprazole Sodium, Synthroid, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JEFFREY GILDOW, PHARM.D. accept Medicare?
JEFFREY GILDOW, PHARM.D. appears in CMS Medicare data with 397 Part D claims and 83 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JEFFREY GILDOW, PHARM.D.'s credentials?
JEFFREY GILDOW, PHARM.D.'s NPI is 1750538872 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology